1. Home
  2. LAES vs EIKN Comparison

LAES vs EIKN Comparison

Compare LAES & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

N/A

Current Price

$0.96

Market Cap

368.9M

Sector

Technology

ML Signal

N/A

Logo Eikon Therapeutics Inc. Common Stock

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$4.76

Market Cap

316.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAES
EIKN
Founded
2022
2019
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.9M
316.3M
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
LAES
EIKN
Price
$0.96
$4.76
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$5.88
★ $24.00
AVG Volume (30 Days)
★ 3.7M
511.7K
Earning Date
09-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$59.43
N/A
Revenue Next Year
$41.92
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$4.72
52 Week High
$5.48
$16.50

Technical Indicators

Market Signals
Indicator
LAES
EIKN
Relative Strength Index (RSI) 27.57 33.10
Support Level N/A N/A
Resistance Level $2.56 $6.82
Average True Range (ATR) 0.12 0.63
MACD -0.01 -0.04
Stochastic Oscillator 3.16 3.10

Price Performance

Historical Comparison
LAES
EIKN

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About EIKN Eikon Therapeutics Inc. Common Stock

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Share on Social Networks: